HB 656: The Impact Of Financial Initiatives For Commercially Insured Members By Drug Manufacturers On Prescription Drug Prices and Health Insurance Premiums

HB 656: The Impact Of Financial Initiatives For Commercially Insured Members By Drug Manufacturers On Prescription Drug Prices and Health Insurance Premiums

This bill establishes a commission to study the impact of financial initiatives for commercially insured members by drug manufacturers on prescription drug prices and health insurance premiums.

New Futures supports HB 656. Click here to read.

Bill Status
  • Committee
  • Public Hearing
  • Executive Session
  • Full Body Vote
  • Committee
  • Public Hearing
  • Executive Session
  • Full Body Vote